| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTRA | Common Stock | Options Exercise | $268 | +25 | +0.03% | $10.73* | 75K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Options Exercise | $49.1K | +5.29K | +7.05% | $9.29* | 80.3K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Options Exercise | $42.2K | +3.24K | +4.04% | $13.01* | 83.5K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Options Exercise | $99.1K | +7.62K | +9.12% | $13.01* | 91.1K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Options Exercise | $65.7K | +3.24K | +3.56% | $20.27 | 94.4K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Options Exercise | $116K | +4.57K | +4.84% | $25.46 | 98.9K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Options Exercise | $239K | +9.38K | +9.48% | $25.46 | 108K | Aug 12, 2021 | Direct | |
| transaction | NTRA | Common Stock | Sale | -$941K | -9.29K | -8.58% | $101.24 | 99K | Aug 12, 2021 | Direct | F1, F2 |
| transaction | NTRA | Common Stock | Sale | -$2.45M | -24.1K | -24.3% | $101.82 | 75K | Aug 12, 2021 | Direct | F1, F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -25 | -50% | $0.00 | 25 | Aug 12, 2021 | Common Stock | 25 | $10.73 | Direct | F5 |
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -5.29K | -16.55% | $0.00 | 26.7K | Aug 12, 2021 | Common Stock | 5.29K | $9.29 | Direct | F6 |
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -3.24K | -7.74% | $0.00 | 38.7K | Aug 12, 2021 | Common Stock | 3.24K | $13.01 | Direct | F7 |
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -7.62K | -16.39% | $0.00 | 38.9K | Aug 12, 2021 | Common Stock | 7.62K | $13.01 | Direct | F8 |
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -3.24K | -6.73% | $0.00 | 44.9K | Aug 12, 2021 | Common Stock | 3.24K | $20.27 | Direct | F9 |
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -4.57K | -16.39% | $0.00 | 23.3K | Aug 12, 2021 | Common Stock | 4.57K | $25.46 | Direct | F10 |
| transaction | NTRA | Stock Option (right to buy) | Options Exercise | $0 | -9.38K | -25% | $0.00 | 28.1K | Aug 12, 2021 | Common Stock | 9.38K | $25.46 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021 as amended on May 14, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.45. to $101.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.46 to $102.28 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | These reported shares are subject to restrictions in the Lock-Up Letter Agreement. |
| F5 | The option shares are fully vested and may be exercised at any time. |
| F6 | The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. |
| F7 | The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. |
| F8 | This option vested and became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of March 9, 2021, the criteria was satisfied with respect to 31,250 additional shares. |
| F9 | The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. |
| F10 | The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of June 3, 2021, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares. |
| F11 | The option became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of July 1, 2021, the criteria was satisfied with respect to 18,750 additional shares. |